Publications by authors named "Konstantinos Mathioudakis"

Claim this Profile
R
Real-World Prevalence, Treatment Patterns, and Economic Impact of EGFR- and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Analysis from Greece.
George Gourzoulidis, Catherine Kastanioti, George Mavridoglou, Theodore Kotsilieris, Anastasios Tsolakidis, Konstantinos Mathioudakis

Curr Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of the Patient Reported Indicator Surveys (PaRIS) in Greece: A Cornerstone in Systematic Investigation of Patient Reported Experiences and Outcomes from Primary Health Care Services.
Olga Siskou, Olympia Konstantakopoulou, Petros Galanis, Venetia Vildiridi, Vasileios Kontozamanis, Konstantinos Mathioudakis

Stud Health Technol Inform· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics.
Elizabeth Lazaridou, Zoe Apalla, Stylianos Ravanidis, Garyfallia Stefanou, Katerina Vellopoulou, Konstantinos Mathioudakis

Arch Dermatol Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.
Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Anastasios Tsolakidis, Konstantinos Mathioudakis

Rheumatol Int· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug survival of biologics in patients with psoriasis: real-world evidence for Greece during the period 2016-2020.
Elizabeth Lazaridou, Georgia Kourlaba, Stylianos Ravanidis, George Gounelas, Garyfallia Stefanou, Konstantinos Mathioudakis

Clin Exp Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on treatment patterns in at least high cardiovascular risk patients on dual and triple lipid lowering therapy in a Hellenic nationwide e-prescription database.
Dimitrios Terentes-Printzios, Ioanna Dima, Panorios Benardos, Panagiota Mitrou, Konstantinos Mathioudakis

Int J Cardiol Cardiovasc Risk Prev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study.
Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Konstantinos Mathioudakis, George Konstantonis

Rheumatology (Oxford)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study.
Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Konstantinos Mathioudakis, Anastasios Tsolakidis

Rheumatology (Oxford)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in Greece.
Maria P Yavropoulou, Polyzois Makras, Kostas Athanasakis, Vasiliki-Kalliopi Bournia, Konstantinos Mathioudakis

Arch Osteoporos· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.
Vasiliki-Kalliopi Bournia, George E Fragoulis, Panagiota Mitrou, Konstantinos Mathioudakis, Anastasios Tsolakidis

RMD Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction and switching of biologic agents are associated with antidepressant and anxiolytic medication use: data on 42 815 real-world patients with inflammatory rheumatic disease.
Vasiliki-Kalliopi Bournia, Maria G Tektonidou, Dimitrios Vassilopoulos, Katerina Laskari, Stylianos Panopoulos, Konstantinos Mathioudakis

RMD Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis